UNSPSC 51284039: Oxytetracycline hydrochloride

This classification denotes a tetracycline antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4U7K4N52ZM. European Medicines Agency schedules Oxytetracycline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14740MIG. Oxytetracycline hydrochloride generally arises in the molecular formula C22H24N2O9.CLH. The term 'oxytetracycline hydrochloride' is a U.S. Pharmacopeial Convention designation.

UNSPSC 51284039 Oxytetracycline hydrochloride is a Commodity code for a specific pharmaceutical active ingredient, but recent state and local procurement activity under this code shows limited direct solicitation. The one recent opportunity in the dataset—a piggyback pharmaceutical warehouse award by the Illinois Department of Public Health through the MMCAP Infuse consortium—supplied Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets to Chartwell Rx LLC, not oxytetracycline. State and local governments do procure pharmaceuticals through cooperative purchasing agreements and fixed-price warehouse contracts with multi-year renewal terms, typically for emergency preparedness, public health, or community health programs. These purchases often flow through established consortia and piggyback frameworks that allow jurisdictions to leverage prior competitive procurements rather than re-bid commodity pharmaceuticals annually.

Geographic activity and recent opportunities are limited under this specific code. The Illinois Department of Public Health's MMCAP Infuse award (August 28, 2026, with a three-year contract total of $2,999,999.11) and Seminole County, Florida's separate procurement for naloxone and drug deactivation systems (IFB posted June 30, 2026, with a July 26, 2023 response deadline) represent the only indexed recent activity, but neither directly solicited oxytetracycline. Pursuit under this Commodity code appears inadvisable at present; vendors in pharmaceutical supply should monitor higher-tier Family codes for state and local pharmaceutical procurement activity and watch for opportunities tagged to cooperative purchasing vehicles like MMCAP that may include oxytetracycline as a line item.